AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Revenue growth (%)

Nxera Pharma Co., Ltd.【JP:4565】

Market cap
¥86.8B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Dec 31, 20252.7-97.85%
Dec 31, 2024125.9-799.28%
Dec 31, 2023-18+48.76%
Dec 31, 2022-12.1-112.06%
Dec 31, 2021100.3-1203.63%
Dec 31, 2020-9.1-122.82%
Dec 31, 201939.8-146.98%
Dec 31, 2018-84.8+34.19%
Mar 31, 2018-63.2-147.92%
Mar 31, 2017131.9+8.07%
Mar 31, 2016122+57.61%
Mar 31, 201577.4+1265.61%
Mar 31, 20145.7-95.54%
Mar 31, 2013127.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)